SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hans Törnblom, Magnus Simrén, Hasse Abrahamsson, Gastrointestinal motility and neurogastroenterology, Scandinavian Journal of Gastroenterology, 2015, 1

    CrossRef

  2. 2
    Sung Eun Kim, Medical treatment of functional dyspepsia, Kosin Medical Journal, 2015, 30, 1, 1

    CrossRef

  3. 3
    Michael Camilleri, Peripheral Mechanisms in Appetite Regulation, Gastroenterology, 2015, 148, 6, 1219

    CrossRef

  4. 4
    Andrea Shin, John M. Wo, Therapeutic Applications of Ghrelin Agonists in the Treatment of Gastroparesis, Current Gastroenterology Reports, 2015, 17, 2

    CrossRef

  5. 5
    Sarah Marrinan, Anton V. Emmanuel, David J. Burn, Delayed gastric emptying in Parkinson's disease, Movement Disorders, 2014, 29, 1
  6. 6
    William L Hasler, Emerging drugs for the treatment of gastroparesis, Expert Opinion on Emerging Drugs, 2014, 19, 2, 261

    CrossRef

  7. 7
    Liza K. Phillips, Adam M. Deane, Karen L. Jones, Chris K. Rayner, Michael Horowitz, Gastric emptying and glycaemia in health and diabetes mellitus, Nature Reviews Endocrinology, 2014, 11, 2, 112

    CrossRef

  8. 8
    Prateek Wali, Jeremy King, Zhaoping He, Dalal Tonb, Karoly Horvath, Ghrelin and Obestatin Levels in Children With Failure to Thrive and Obesity, Journal of Pediatric Gastroenterology and Nutrition, 2014, 58, 3, 376

    CrossRef

  9. 9
    Jan Tack, Christophe Vanormelingen, Management of Gastroparesis: Beyond Basics, Current Treatment Options in Gastroenterology, 2014, 12, 4, 468

    CrossRef

  10. 10
    H. Karasawa, C. Pietra, C. Giuliano, S. Garcia-Rubio, X. Xu, S. Yakabi, Y. Taché, L. Wang, New ghrelin agonist, HM01 alleviates constipation and L-dopa-delayed gastric emptying in 6-hydroxydopamine rat model of Parkinson's disease, Neurogastroenterology & Motility, 2014, 26, 12
  11. 11
    Lex Van der Ploeg, Haley Laken, Shubh Sharma, Rakesh Datta, Heather Halem, Jesse Dong, Caroline Touvay, Marc Teillot, Patrick Noonan, Lou Tartaglia, Liz Stoner, Bart Henderson, Keith Gottesdiener, Michael Culler, Preclinical gastrointestinal prokinetic efficacy and endocrine effects of the ghrelin mimetic RM-131, Life Sciences, 2014, 109, 1, 20

    CrossRef

  12. 12
    M. Camilleri, A. Acosta, A ghrelin agonist fails to show benefit in patients with diabetic gastroparesis: let's not throw the baby out with the bath water, Neurogastroenterology & Motility, 2013, 25, 11
  13. 13
    N. Ejskjaer, J. M. Wo, T. Esfandyari, M. Mazen Jamal, G. Dimcevski, L. Tarnow, R. A. Malik, P. M. Hellström, E. Mondou, J. Quinn, F. Rousseau, R. W. McCallum, A phase 2a, randomized, double-blind 28-day study of TZP-102 a ghrelin receptor agonist for diabetic gastroparesis, Neurogastroenterology & Motility, 2013, 25, 2
  14. 14
    Yong Sam Kwon, Miwon Son, DA-9701: A New Multi-Acting Drug for the Treatment of Functional Dyspepsia, Biomolecules and Therapeutics, 2013, 21, 3, 181

    CrossRef

  15. 15
    Sony S Thazhath, Karen L Jones, Michael Horowitz, Christopher K Rayner, Diabetic gastroparesis: recent insights into pathophysiology and implications for management, Expert Review of Gastroenterology & Hepatology, 2013, 7, 2, 127

    CrossRef

  16. 16
    Luo Xu, Zhuling Qu, Feifei Guo, Mingjie Pang, Shengli Gao, Hai Zhu, Fang Gu, Xiangrong Sun, Effects of ghrelin on gastric distention sensitive neurons in the arcuate nucleus of hypothalamus and gastric motility in diabetic rats, Peptides, 2013, 48, 137

    CrossRef

  17. 17
    Shiying Li, Roland Maude-Griffin, Yan Sun, Warren Starkebaum, Jiande D. Z. Chen, Food Intake and Body Weight Responses to Intermittent vs. Continuous Gastric Electrical Stimulation in Diet-Induced Obese Rats, Obesity Surgery, 2013, 23, 1, 71

    CrossRef

  18. 18
    B. Avau, F. Carbone, J. Tack, I. Depoortere, Ghrelin signaling in the gut, its physiological properties, and therapeutic potential, Neurogastroenterology & Motility, 2013, 25, 9
  19. 19
    Y. Falkén, D.-L. Webb, M. Abraham-Nordling, U. Kressner, P. M. Hellström, E. Näslund, Intravenous ghrelin accelerates postoperative gastric emptying and time to first bowel movement in humans, Neurogastroenterology & Motility, 2013, 25, 6
  20. 20
    Julie E Stevens, Karen L Jones, Christopher K Rayner, Michael Horowitz, Pathophysiology and pharmacotherapy of gastroparesis: current and future perspectives, Expert Opinion on Pharmacotherapy, 2013, 14, 9, 1171

    CrossRef

  21. 21
    Michael Camilleri, Pharmacological agents currently in clinical trials for disorders in neurogastroenterology, Journal of Clinical Investigation, 2013, 123, 10, 4111

    CrossRef

  22. You have free access to this content22
    R. W. McCallum, A. Lembo, T. Esfandyari, B. R. Bhandari, N. Ejskjaer, C. Cosentino, N. Helton, E. Mondou, J. Quinn, F. Rousseau, Phase 2b, randomized, double-blind 12-week studies of TZP-102, a ghrelin receptor agonist for diabetic gastroparesis, Neurogastroenterology & Motility, 2013, 25, 11
  23. 23
    Jung Hwan Oh, Pankaj J Pasricha, Recent Advances in the Pathophysiology and Treatment of Gastroparesis, Journal of Neurogastroenterology and Motility, 2013, 19, 1, 18

    CrossRef

  24. You have free access to this content24
    J. Luttikhold, F. M. Ruijter, K. Norren, M. Diamant, R. F. Witkamp, P. A. M. Leeuwen, M. A. R. Vermeulen, Review article: the role of gastrointestinal hormones in the treatment of delayed gastric emptying in critically ill patients, Alimentary Pharmacology & Therapeutics, 2013, 38, 6
  25. 25
    Andrea Shin, Michael Camilleri, Irene Busciglio, Duane Burton, Steven A. Smith, Adrian Vella, Michael Ryks, Deborah Rhoten, Alan R. Zinsmeister, The Ghrelin Agonist RM-131 Accelerates Gastric Emptying of Solids and Reduces Symptoms in Patients With Type 1 Diabetes Mellitus, Clinical Gastroenterology and Hepatology, 2013, 11, 11, 1453

    CrossRef

  26. 26
    D A Katzka, E V Loftus, M Camilleri, Evolving Molecular Targets in the Treatment of Nonmalignant Gastrointestinal Diseases, Clinical Pharmacology & Therapeutics, 2012, 92, 3
  27. 27
    J. Wixner, P. Karling, A. Rydh, R. Hörnsten, U. Wiklund, I. Anan, O. B. Suhr, Gastric emptying in hereditary transthyretin amyloidosis: the impact of autonomic neuropathy, Neurogastroenterology & Motility, 2012, 24, 12
  28. 28
    Klaus Bielefeldt, Gastroparesis: Concepts, Controversies, and Challenges, Scientifica, 2012, 2012, 1

    CrossRef

  29. 29
    Grant Bochicchio, Philippa Charlton, John C. Pezzullo, Gordana Kosutic, Anthony Senagore, Ghrelin Agonist TZP-101/Ulimorelin Accelerates Gastrointestinal Recovery Independently of Opioid Use and Surgery Type: Covariate Analysis of Phase 2 Data, World Journal of Surgery, 2012, 36, 1, 39

    CrossRef

  30. You have free access to this content30
    B. E. Lacy, N. J. Talley, G. R. Locke, E. P. Bouras, J. K. DiBaise, H. B. El-Serag, B. P. Abraham, C. W. Howden, P. Moayyedi, C. Prather, Review article: current treatment options and management of functional dyspepsia, Alimentary Pharmacology & Therapeutics, 2012, 36, 1
  31. 31
    Eveline Deloose, Pieter Janssen, Inge Depoortere, Jan Tack, The migrating motor complex: control mechanisms and its role in health and disease, Nature Reviews Gastroenterology & Hepatology, 2012, 9, 5, 271

    CrossRef

  32. 32
    Jessica Chang, Christopher K Rayner, Karen L Jones, Michael Horowitz, Diabetic gastroparesis—Backwards and forwards, Journal of Gastroenterology and Hepatology, 2011, 26,
  33. 33
    Jan Tack, Pieter Janssen, Emerging drugs for functional dyspepsia, Expert Opinion on Emerging Drugs, 2011, 16, 2, 283

    CrossRef

  34. 34
    Derek M. Tang, Frank K. Friedenberg, Gastroparesis: Approach, Diagnostic Evaluation, and Management, Disease-a-Month, 2011, 57, 2, 74

    CrossRef

  35. 35
    Penny Jeffery, Victoria McDonald, Emma Tippett, Michael McGuckin, Ghrelin in gastrointestinal disease, Molecular and Cellular Endocrinology, 2011, 340, 1, 35

    CrossRef

  36. 36
    Syrine Gallas, Sergueï O. Fetissov, Ghrelin, appetite and gastric electrical stimulation, Peptides, 2011, 32, 11, 2283

    CrossRef

  37. 37
    Eric Marsault, Mark L. Peterson, Macrocycles Are Great Cycles: Applications, Opportunities, and Challenges of Synthetic Macrocycles in Drug Discovery, Journal of Medicinal Chemistry, 2011, 54, 7, 1961

    CrossRef

  38. 38
    Seiji Futagami, Mayumi Shimpuku, Yan Yin, Tomotaka Shindo, Yasuhiro Kodaka, Hiroyuki Nagoya, Shoko Nakazawa, Mayumi Fujimoto, Nikki Izumi, Noriko Ohishi, Tetsuro Kawagoe, Akane Horie, Katsuhiko Iwakiri, Choitsu Sakamoto, Pathophysiology of Functional Dyspepsia, Journal of Nippon Medical School, 2011, 78, 5, 280

    CrossRef

  39. 39
    Marcus M. Unger, Jens C. Möller, Katharina Mankel, Karla M. Eggert, Katharina Bohne, Maren Bodden, Karin Stiasny-Kolster, Peter H. Kann, Geert Mayer, Johannes J. Tebbe, Wolfgang H. Oertel, Postprandial ghrelin response is reduced in patients with Parkinson’s disease and idiopathic REM sleep behaviour disorder: a peripheral biomarker for early Parkinson’s disease?, Journal of Neurology, 2011, 258, 6, 982

    CrossRef

  40. 40
    J. M. Wo, N. Ejskjaer, P. M. Hellström, R. A. Malik, J. C. Pezzullo, L. Shaughnessy, P. Charlton, G. Kosutic, R. W. McCallum, Randomised clinical trial: ghrelin agonist TZP-101 relieves gastroparesis associated with severe nausea and vomiting – randomised clinical study subset data, Alimentary Pharmacology & Therapeutics, 2011, 33, 6
  41. 41
    James W. Dale, Gregory J. Hollingworth, Jeffrey M. McKenna, Annual Reports in Medicinal Chemistry Volume 46, 2011,

    CrossRef

  42. 42
    Jessica Chang, Christopher K. Rayner, Karen L. Jones, Michael Horowitz, Diabetic Gastroparesis and Its Impact on Glycemia, Endocrinology and Metabolism Clinics of North America, 2010, 39, 4, 745

    CrossRef

  43. 43
    Uazman Alam, Omar Asghar, Rayaz Ahmed Malik, Diabetic gastroparesis: Therapeutic options, Diabetes Therapy, 2010, 1, 1, 32

    CrossRef

  44. 44
    Uazman Alam, Omar Asghar, Rayaz Ahmed Malik, Diabetic gastroparesis: Therapeutic options, Diabetes Therapy, 2010, 1, 1, 32

    CrossRef

  45. 45
    Kenneth L. Koch, Gastric Electrical Stimulation and the “Eye of the Beholder”, Clinical Gastroenterology and Hepatology, 2010, 8, 11, 908

    CrossRef

  46. 46
    Jan Tack, Pieter Janssen, Gastroduodenal motility, Current Opinion in Gastroenterology, 2010, 26, 6, 647

    CrossRef

  47. 47
    Ghrelin receptor agonists: a new class of prokinetic agents, Neurogastroenterology & Motility, 2010, 22, 10
  48. 48
    Johannes D. Veldhuis, Cyril Y. Bowers, Integrating GHS into the Ghrelin System, International Journal of Peptides, 2010, 2010, 1

    CrossRef

  49. 49
    Z. T. Bloomgarden, Neuropathy, Retinopathy, and Glucose-Lowering Treatments, Diabetes Care, 2010, 33, 6, e73

    CrossRef

  50. 50
    Ping-Huei Tseng, Ming-Shiang Wu, Jia-Horng Kao, Recent Advances in Clinical Application of Gut Hormones, Journal of the Formosan Medical Association, 2010, 109, 12, 859

    CrossRef

  51. 51
    N. Ejskjaer, G. Dimcevski, J. Wo, P. M. Hellström, L. C. Gormsen, I. Sarosiek, E. Søfteland, T. Nowak, J. C. Pezzullo, L. Shaughnessy, G. Kosutic, R. Mccallum, Safety and efficacy of ghrelin agonist TZP-101 in relieving symptoms in patients with diabetic gastroparesis: a randomized, placebo-controlled study, Neurogastroenterology & Motility, 2010, 22, 10
  52. 52
    Irinel Popescu, Phillip R. Fleshner, John C. Pezzullo, Philippa A. Charlton, Gordana Kosutic, Anthony J. Senagore, The Ghrelin Agonist TZP-101 for Management of Postoperative Ileus After Partial Colectomy: A Randomized, Dose-Ranging, Placebo-Controlled Clinical Trial, Diseases of the Colon & Rectum, 2010, 53, 2, 126

    CrossRef

  53. 53
    Hanaa S. Sallam, Jiande D. Z. Chen, The Prokinetic Face of Ghrelin, International Journal of Peptides, 2010, 2010, 1

    CrossRef

  54. 54
    Betty De Smet, Anna Mitselos, Inge Depoortere, Motilin and ghrelin as prokinetic drug targets, Pharmacology & Therapeutics, 2009, 123, 2, 207

    CrossRef

  55. 55
    Chinmay S. Marathe, Liza Phillips, Michael Horowitz, Autonomic neuropathy,
  56. 56
    Gareth J. Sanger, John Broad, David H. Alpers, Translation of Motilin and Ghrelin Receptor Agonists into Drugs for Gastrointestinal Disorders,
  57. 57
    Mark L. Peterson, Hamid Hoveyda, Graeme Fraser, Éric Marsault, René Gagnon, Use of Macrocycles in Drug Design Exemplified with Ulimorelin, a Potential Ghrelin Agonist for Gastrointestinal Motility Disorders,